Medication info
Candesartan 16 mg (Candesartan Cilexetil)

Candesartan 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Kyungbo Pharmaceutical Co., Ltd.
Appearance
A pale yellow-pink tablet with a convex shape on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201907938 · Approved 2019.11.14 · Insurance code 665002790

Summary

Main use
Treatment of essential hypertension and heart failure
Who takes it
Adults · Children
Adult dose
This medication should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
Child dose
1. Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Kyungbo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure

  • Essential hypertension
  • heart failure
  • impaired left ventricular systolic function
  • reduced left ventricular ejection fraction
View approved original text

This medication is used to control blood pressure in patients with essential hypertension, and is also beneficial for patients with heart failure, specifically for those with decreased left ventricular systolic function. It can be used in patients with a left ventricular ejection fraction of 40% or lower who require additional treatment with ACE inhibitors or who have poor tolerance to ACE inhibitors. Therefore, it is effective in improving symptoms of hypertension and heart failure.

How to take

Adult dose

This medication should be taken at the same time each day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatment should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Elderly patients: No adjustment of the initial dose is necessary. 3) Patients with intravascular volume depletion: For patients at high risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those on hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, depending on the patient's tolerability. 2) Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.

Child dose

1. Essential hypertension: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, and nursing mothers should not take this medication. Patients who are allergic to this medication or its components, those with severe liver disease, or hereditary angioedema should not use this medication. Elderly patients, those with hyperkalemia, cirrhosis, heart valve disease, and renal impairment should use this medication with caution, as there is a risk of heart or cerebrovascular issues due to blood pressure lowering. Side effects such as dizziness, back pain, or respiratory infections may occur during treatment; in severe cases, renal function deterioration, hypotension, or hyperkalemia may develop, so regular blood tests and kidney function assessments are important. If blood pressure drops too low or severe side effects occur, consult medical personnel immediately; particularly patients with heart failure may require dosage adjustment and monitoring of their condition. When used in combination with other antihypertensive agents, the blood pressure-lowering effect may increase, so caution is necessary with concurrent use, and when used with potassium-sparing diuretics, there is an increased risk of hyperkalemia, requiring frequent monitoring of blood potassium levels. It is important to inform your doctor before undergoing surgery or anesthesia, as this medication may cause hypotension during the procedure. The safety of this medication in children and adolescents has not been established, so it is not recommended for those under 18 years of age. Caution is advised during driving or operating machinery, as dizziness or drowsiness may occur. In case of overdose, blood pressure may drop significantly, requiring immediate medical attention, and this medication is not removed by dialysis. Store this medication out of reach of children and do not transfer it to another container for safety precautions.

Side effects

  • Dizziness
  • low back pain
  • respiratory infection
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • fatigue
  • peripheral edema
  • chest pain
  • headache
Show 70 more
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • weakness
  • fever
  • sensory disturbances
  • dyspepsia
  • gastritis
  • tachycardia
  • palpitations
  • increase in creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • somnolence
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • renal impairment
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • tremor
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disorders
  • decreased libido
  • amnesia
  • loss of appetite
  • increased appetite
  • tinnitus
  • dysgeusia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication can be sensitive to air and moisture, so it must be stored in a tightly closed container. It is best to maintain a storage temperature between 1°C and 30°C. Storing it this way will help preserve its effectiveness for a longer period.

Appearance and packaging

Appearance

A pale yellow-pink tablet with a convex shape on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.